Enfermedades gastrointestinales y hepáticas - GIC 21/123
Publications (556) Publications auxquelles un chercheur a participé
2024
-
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels
Clinical Gastroenterology and Hepatology
-
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death
Scientific reports, Vol. 14, Núm. 1, pp. 3000
-
Author response to: Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST)
British Journal of Surgery
-
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions
Gastric Cancer
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Therapeutic Advances in Gastroenterology, Vol. 17
-
Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer
Colorectal Disease
-
Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer
Colorectal Disease, Vol. 26, Núm. 5, pp. 926-931
-
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259
-
Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance
American Journal of Gastroenterology, Vol. 119, Núm. 4, pp. 646-654
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, pp. 257-264
-
Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma
Gastroenterology, Vol. 166, Núm. 5, pp. 886-901.e7
-
Fragility Index, Reverse Fragility Index, Fragility Quotients, and Susceptibility Index. Novel tools for assessing of randomized clinical trials
Cirugia Espanola, Vol. 102, Núm. 1, pp. 41-43
-
Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma
Hepatology, Vol. 79, Núm. 4, pp. 941-958
-
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
Journal of Crohn's and Colitis, Vol. 18, Núm. 3, pp. 349-359
-
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 4, pp. 578-588
-
Non-specific protection against severe COVID-19 associated to typhoid fever and DTP vaccination
Heliyon, Vol. 10, Núm. 9
-
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management
United European Gastroenterology Journal, Vol. 12, Núm. 1, pp. 122-138
-
Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry
Cirugia Espanola
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
-
Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium
Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 293-318